Likewise, Guerineau et al. [28] demonstrated on a cohort of CML patients that was not divided into age groups that the presence of mutations in epigenetic genes at diagnosis was linked to a higher cumulative incidence of BCR::ABL1 KD mutations (p = 0.015). The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.